Inovio Pharmaceuticals Inc (INO) — Cash Flow-to-Debt Ratio
Inovio Pharmaceuticals Inc (INO) has a Cash Flow-to-Debt Ratio of -0.28x as of September 2025, meaning its operating cash flow of $-21.57 Million could theoretically repay 0% of its total liabilities ($77.11 Million) in one year. See Inovio Pharmaceuticals Inc (INO) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Inovio Pharmaceuticals Inc Cash Flow-to-Debt Ratio (1998–2024)
Historical debt coverage capacity for Inovio Pharmaceuticals Inc across 27 annual periods. Also explore net asset growth rate of Inovio Pharmaceuticals Inc to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Inovio Pharmaceuticals Inc (1998–2024)
Year-by-year debt coverage analysis for Inovio Pharmaceuticals Inc. For market capitalisation and broader financial context, see INO market cap.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -2.33x | $-104.08 Million | $44.69 Million | ▼ -0.4% |
| 2023 | -2.32x | $-124.37 Million | $53.60 Million | ▼ -35.4% |
| 2022 | -1.71x | $-216.22 Million | $126.17 Million | ▲ +23.5% |
| 2021 | -2.24x | $-215.71 Million | $96.27 Million | ▲ +1.0% |
| 2020 | -2.26x | $-177.98 Million | $78.63 Million | ▼ -220.5% |
| 2019 | -0.71x | $-97.85 Million | $138.55 Million | ▲ +57.7% |
| 2018 | -1.67x | $-73.55 Million | $44.08 Million | ▼ -18.1% |
| 2017 | -1.41x | $-63.21 Million | $44.75 Million | ▼ -13.6% |
| 2016 | -1.24x | $-62.56 Million | $50.33 Million | ▼ -278.8% |
| 2015 | -0.33x | $-12.44 Million | $37.91 Million | ▲ +77.7% |
| 2014 | -1.47x | $-29.82 Million | $20.25 Million | ▼ -238.8% |
| 2013 | -0.43x | $-15.38 Million | $35.38 Million | ▲ +80.0% |
| 2012 | -2.17x | $-22.31 Million | $10.28 Million | ▼ -45.5% |
| 2011 | -1.49x | $-19.76 Million | $13.24 Million | ▼ -12.0% |
| 2010 | -1.33x | $-11.94 Million | $8.97 Million | ▼ -83.9% |
| 2009 | -0.72x | $-14.08 Million | $19.44 Million | ▼ -29.4% |
| 2008 | -0.56x | $-11.13 Million | $19.88 Million | ▲ +57.5% |
| 2007 | -1.32x | $-11.51 Million | $8.74 Million | ▼ -132.8% |
| 2006 | -0.57x | $-7.04 Million | $12.45 Million | ▲ +74.7% |
| 2005 | -2.24x | $-12.34 Million | $5.51 Million | ▼ -77.9% |
| 2004 | -1.26x | $-6.80 Million | $5.40 Million | ▲ +45.9% |
| 2003 | -2.33x | $-2.75 Million | $1.18 Million | ▲ +20.5% |
| 2002 | -2.93x | $-4.96 Million | $1.69 Million | ▲ +41.6% |
| 2001 | -5.01x | $-8.37 Million | $1.67 Million | ▲ +9.0% |
| 2000 | -5.51x | $-8.79 Million | $1.60 Million | ▼ -90.7% |
| 1999 | -2.89x | $-6.30 Million | $2.18 Million | ▲ +31.2% |
| 1998 | -4.20x | $-6.30 Million | $1.50 Million | — |